One-year clinical trial data for the next-generation, investigational, Sphere-360™ single-shot PFA catheter show impressive safety, performance, and efficiency results for paroxysmal Afib Dual-energy ...
First-of-its-kind, rotation-free single-shot PFA catheter supported by strong safety and efficacy data adds to the groundbreaking Affera family of technologies in Europe Successful completion of first ...
EHRA late-breaking data: Results highlight efficacy, safety, and durability of the novel PFA catheter that is fully integrated with Affera™ Mapping and Ablation System The Sphere-360 catheter was ...
The clinical trial will assess the safety and effectiveness of a pulmonary vein isolation-only strategy to treat patients with persistent atrial fibrillation using the company’s Arctic Front Advance ...
We recently compiled a list of the Top 10 Medical AI Stocks on Wall Street’s Radar. In this article, we are going to take a look at where Medtronic plc (NYSE:MDT) stands against the other medical AI ...
GALWAY, Ireland, Jan. 23, 2026 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced two major milestones for the Affera™ Sphere-360™ catheter, a first-of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results